.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Queensland Health
UBS
Mallinckrodt
Daiichi Sankyo
Cantor Fitzgerald
Johnson and Johnson
Federal Trade Commission
Covington
Teva

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: High affinity nucleic acid ligands of complement system proteins
Abstract:Methods are described for the identification and preparation of high-affinity Nucleic Acid Ligands to Complement System Proteins. Methods are described for the identification and preparation of high affinity Nucleic Acid Ligands to Complement System Proteins C1q, C3 and C5. Included in the invention are specific RNA ligands to C1q, C3 and C5 identified by the SELEX method.
Inventor(s): Biesecker; Gregory (Boulder, CO), Gold; Larry (Boulder, CO)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Filing Date:Sep 29, 1998
Application Number:09/163,025
Claims:1. A purified and isolated non-naturally occurring Nucleic Acid Ligand to C5, wherein said ligand is an RNA ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.

2. The Nucleic Acid Ligand of claim 1 wherein said ligand is substantially homologous to and has substantially the same ability to bind said C5 as a ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.

3. The Nucleic Acid Ligand of claim 1 wherein said ligand has substantially the same structure and has substantially the same ability to bind said C5 as a ligand selected from the group consisting of SEQ ID NOS: 75, 160-196.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Colorcon
Cerilliant
Chubb
Healthtrust
Deloitte
QuintilesIMS
Argus Health
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot